A pair of investor calls on Jan. 22 added clarity to the rapidly evolving cardiac ablation market with Abbott Laboratories and Johnson & Johnson providing updates on their pulsed field ablation ...

Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...

In 2024, Abbott's EP business demonstrated strength thanks to its preferred mapping systems, even though it is late to market with its own pulsed field ablation technology. However, EP growth ...

The Clarivate e-book highlights new medtech breakthroughs in the pulsed field ablation (PFA) market, forecasting its future growth and showcasing the technology's potential to transform the ...

Boston Scientific, with approximately 10,000 employees in Minnesota, reported a fourth-quarter adjusted net profit of $1 ...

One year into the U.S. launch of pulsed field ablation systems from Boston Scientific and Medtronic ... divided between Boston Scientific (58%), Medtronic (28%), J&J (11%), and Abbott (3%). In 2026, ...

Title: Nanosecond Pulsed Field Ablation for Atrial Fibrillation Live ... and 3D mapping and navigation with the Abbott Ensite X system as part of a 3D navigation workflow.

New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment. LONDON, Feb. 4, 2025 /CNW/ -- Clarivate Plc (NYSE:CLVT) a leadi ...